How it Works
This therapy is personalized and customizable for the patient. It takes a few simple steps. First, white blood cells are removed from a donor. This donor must have previously donated their stem cells to the blood cancer patient. Next, tumor-specific immune cells are generated. Finally, these new cells are administered back to the patient through their blood stream. These new cells attack the cancerous cells in the body.
The very first patient to be given this therapy received it in April. They are now recovering in their home. Doctors are monitoring him to determine the efficacy of the treatment. They believe this observation stage may take months.
Considering how limited the treatment options for AML and MDS currently are, there is an urgent need for more research. This therapy could be life-saving for patients but more investigation is still needed.
This company believes that personalized therapies are the future of healthcare for cancer patients. Antigen-Specific T-Cell Therapy is just one of the moves in this direction.
You can read more about this investigative therapy here.
